Ocular Therapeutix (OCUL) Machine, Furnitures, Fixtures & Other (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Machine, Furnitures, Fixtures & Other (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | 3.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.65 Mn |
| Dec 31, 2025 | 2.22 Mn |
| Sep 30, 2025 | 3.39 Mn |
| Jun 30, 2025 | 2.92 Mn |
| Mar 31, 2025 | 3.60 Mn |
| Dec 31, 2024 | 9.98 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 1.75 Mn |
| Mar 31, 2024 | 1.89 Mn |
| Dec 31, 2023 | 10.44 Mn |
| Sep 30, 2023 | 1.35 Mn |
| Jun 30, 2023 | 1.39 Mn |
| Mar 31, 2023 | 1.04 Mn |
| Dec 31, 2022 | 8.78 Mn |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 1.08 Mn |
| Mar 31, 2022 | 1.55 Mn |
| Dec 31, 2021 | 1.23 Mn |
| Sep 30, 2021 | 1.39 Mn |
| Jun 30, 2021 | 1.08 Mn |
| Mar 31, 2021 | 1.28 Mn |
| Dec 31, 2020 | 868,000.00 |
| Sep 30, 2020 | 701,000.00 |
| Dec 31, 2019 | 1.01 Mn |
| Dec 31, 2018 | 1.39 Mn |
| Dec 31, 2017 | 534,000.00 |
| Sep 30, 2017 | 683,000.00 |
| Jun 30, 2017 | 1.47 Mn |
| Mar 31, 2017 | 1.60 Mn |
| Dec 31, 2016 | 1.02 Mn |
| Sep 30, 2016 | 557,000.00 |
| Jun 30, 2016 | 577,000.00 |
| Mar 31, 2016 | 788,000.00 |
| Dec 31, 2015 | 471,000.00 |
| Sep 30, 2015 | 544,000.00 |
| Jun 30, 2015 | 321,000.00 |
| Mar 31, 2015 | 252,000.00 |
| Dec 31, 2014 | 338,000.00 |
| Sep 30, 2014 | 367,000.00 |
| Jun 30, 2014 | 587,000.00 |
| Dec 31, 2013 | 90,000.00 |